DDOG vs DHR: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Datadog, Inc. · Technology
$223.00
+45.0% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DDOG has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
DHR |
| Current Price |
$223.00 |
$177.17 |
| Fair Value Estimate |
$323.35 |
$192.90 |
| Upside to Fair Value |
+45.0%
|
+8.9%
|
| Market Cap |
$79.4B |
$125.4B |
| Forward P/E |
579.5x
|
34.1x
|
| EV / EBITDA |
351.1x
|
20.8x
|
| Price / Sales |
21.6x
|
5.1x
|
| Price / FCF |
73.5x
|
23.7x
|
| Revenue Growth YoY |
+32.2%
|
+3.7%
|
| Gross Margin |
79.9%
|
60.7%
|
| Operating Margin |
-0.7%
|
21.0%
|
| Return on Equity |
3.8%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.36%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Datadog, Inc. operates a unified observability and security platform that integrates infrastructure monitoring, application performance monitoring, log management, real user monitoring, and security solutions. The company benefits from a high-quality business model characterized by a broad technical moat, led by experienced founders and a stable leadership team with deep engineering expertise. De…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
DDOG |
DHR |
| Zone Low |
$242.51 |
$144.68 |
| Zone High |
$274.85 |
$163.97 |
| In Buy Zone? |
Yes
|
No
|